stocks logo

MRM Valuation

Medirom Healthcare Technologies Inc
$
1.800
-0.11(-5.759%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings

MRM Relative Valuation

MRM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MRM is overvalued; if below, it's undervalued.
Financial AI Agent

Historical Valuation

Medirom Healthcare Technologies Inc (MRM) is now in the Fair zone, suggesting that its current forward PS ratio of 0.25 is considered Fairly compared with the five-year average of 0.00. The fair price of Medirom Healthcare Technologies Inc (MRM) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:1.80
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
12.59
EV/EBITDA
Medirom Healthcare Technologies Inc. (MRM) has a current EV/EBITDA of 12.59. The 5-year average EV/EBITDA is 1.35. The thresholds are as follows: Strongly Undervalued below -5.73, Undervalued between -5.73 and -2.19, Fairly Valued between 4.90 and -2.19, Overvalued between 4.90 and 8.44, and Strongly Overvalued above 8.44. The current Forward EV/EBITDA of 12.59 falls within the Strongly Overvalued range.
18.26
EV/EBIT
Medirom Healthcare Technologies Inc. (MRM) has a current EV/EBIT of 18.26. The 5-year average EV/EBIT is 2.23. The thresholds are as follows: Strongly Undervalued below -9.43, Undervalued between -9.43 and -3.60, Fairly Valued between 8.06 and -3.60, Overvalued between 8.06 and 13.89, and Strongly Overvalued above 13.89. The current Forward EV/EBIT of 18.26 falls within the Strongly Overvalued range.
0.25
PS
Medirom Healthcare Technologies Inc. (MRM) has a current PS of 0.25. The 5-year average PS is 0.02. The thresholds are as follows: Strongly Undervalued below -0.09, Undervalued between -0.09 and -0.03, Fairly Valued between 0.07 and -0.03, Overvalued between 0.07 and 0.13, and Strongly Overvalued above 0.13. The current Forward PS of 0.25 falls within the Strongly Overvalued range.
0.00
P/OCF
Medirom Healthcare Technologies Inc. (MRM) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Medirom Healthcare Technologies Inc. (MRM) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Medirom Healthcare Technologies Inc (MRM) has a current Price-to-Book (P/B) ratio of 2.38. Compared to its 3-year average P/B ratio of -6.48 , the current P/B ratio is approximately -136.68% higher. Relative to its 5-year average P/B ratio of -3.97, the current P/B ratio is about -159.92% higher. Medirom Healthcare Technologies Inc (MRM) has a Forward Free Cash Flow (FCF) yield of approximately -61.35%. Compared to its 3-year average FCF yield of -43.39%, the current FCF yield is approximately 41.40% lower. Relative to its 5-year average FCF yield of -31.93% , the current FCF yield is about 92.14% lower.
2.24
P/B
Median3y
-6.48
Median5y
-3.97
-63.28
FCF Yield
Median3y
-43.39
Median5y
-31.93
AI Stock Picker

Competitors Valuation Multiple

The average P/S ratio for MRM's competitors is 0.45, providing a benchmark for relative valuation. Medirom Healthcare Technologies Inc Corp (MRM) exhibits a P/S ratio of 0.25, which is -44.91% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Intellectia AI SwingMax

Performance Decomposition

1Y
3Y
5Y
Market capitalization of MRM increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of MRM in the past 1 year is driven by Unknown.

FAQ

arrow icon

Is Medirom Healthcare Technologies Inc (MRM) currently overvalued or undervalued?

Medirom Healthcare Technologies Inc (MRM) is now in the Fair zone, suggesting that its current forward PS ratio of 0.25 is considered Fairly compared with the five-year average of 0.00. The fair price of Medirom Healthcare Technologies Inc (MRM) is between to according to relative valuation methord.
arrow icon

What is Medirom Healthcare Technologies Inc (MRM) fair value?

arrow icon

How does MRM's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Medirom Healthcare Technologies Inc (MRM) as of Aug 30 2025?

arrow icon

What is the current FCF Yield for Medirom Healthcare Technologies Inc (MRM) as of Aug 30 2025?

arrow icon

What is the current Forward P/E ratio for Medirom Healthcare Technologies Inc (MRM) as of Aug 30 2025?

arrow icon

What is the current Forward P/S ratio for Medirom Healthcare Technologies Inc (MRM) as of Aug 30 2025?